debutylbupivacaine
CAS No. 15883-20-2
debutylbupivacaine( Desbutylbupivacaine | Debutylbupivacaine | Demethylmepivacaine )
Catalog No. M12267 CAS No. 15883-20-2
It is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 45 | In Stock |
|
25MG | 57 | In Stock |
|
50MG | 98 | In Stock |
|
100MG | 174 | In Stock |
|
200MG | 312 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Namedebutylbupivacaine
-
NoteResearch use only, not for human use.
-
Brief DescriptionIt is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
-
DescriptionIt is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
-
In Vitro——
-
In Vivo——
-
SynonymsDesbutylbupivacaine | Debutylbupivacaine | Demethylmepivacaine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15883-20-2
-
Formula Weight232.32
-
Molecular FormulaC14H20N2O
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESO=C(C1NCCCC1)NC2=C(C)C=CC=C2C
-
Chemical Name2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pihlajam?ki K, et al. Br J Anaesth. 1990 May;64(5):556-62.
molnova catalog
related products
-
CTx0294885
CTX-0294885 is a a novel bisanilino pyrimidine; exhibits inhibitory activity against a broad range of kinases in vitro.
-
GSK2256294A
GSK2256294A is potent, selective inhibitor of recombinant human, rat and mouse sEH with IC50 of 27 pM, 61 pM and 189 pM, respectively.
-
Specneuzhenide
Specneuzhenide is a phenol glycoside isolated from Ligustrum sinense. Specneuzhenide (Nuezhenide) possesses anti-tumor activityhas anti-angiogenic and vision improvement effects.